Indian pharma shifts focus to non-US, domestic markets amid tariff risks (Soban News)

Analysts say Indian pharma firms will increase focus on non-US exports and the domestic market as US tariff threats persist, with firms exploring offshore manufacturing options

​Analysts say Indian pharma firms will increase focus on non-US exports and the domestic market as US tariff threats persist, with firms exploring offshore manufacturing options 

​Latest News [ SOBAN NEWS: International and National ]